Binders in Visual Snow Syndrome, such as lamotrigine or memantine, act by modulating neuronal excitability and regulating glutamatergic neurotransmission in the cortical and thalamic regions. These medications potentially reduce aberrant neural hyperactivity and cortical hyperexcitability, which are believed to contribute to the persistent visual disturbances characteristic of the syndrome.